Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lorenzo Valcanover
Institutions:
The Netherlands Cancer Institute,
Oncode Institute
Observed institutions:
The Netherlands Cancer Institute,
Oncode Institute
ORCID:
0009-0006-7234-6694
Observed ORCID:
0009-0006-7234-6694
OpenAlex ID:
A5115767565
Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation
2025
·
Julien Champagne
, Morten M. Nielsen
, et al.
·
Immunity
·
21
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production
2026
·
Remco Nagel
, Adva Kochavi
, et al.
·
Cancer Research
·
5
Histidine to glutamine substitutants, a regulated process that impacts cell survival and suggests histidine shortage in cancer
2026
·
Domenica Lovecchio
, Pierre-René Körner
, et al.
·
Cell Death Discovery
·
1
PDF
A death sentence for ‘sloppy’ cancers
2026
·
Lorenzo Valcanover
, Reuven Agami
·
Nature
Show more works
View as search
Works count:
4
Citation count:
27
H-index:
2
I10-index:
1
Year
Topic
Type